GlassScriptPhysician profile
Lester C Ong
NPI 1255337119
$2,735.43
in general payments reported to CMS, 2019-2025
42 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $357 · 2021: $406 · 2022: $406 · 2023: $198 · 2024: $433 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.88 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $229.48 | 2019-2021 | |
| Abbvie INC. | $199.05 | 2021-2025 | |
| Novo Nordisk INC | $179.75 | 2019-2024 | Wegovy |
| Astellas Pharma US INC | $122.87 | 2019-2023 | Myrbetriq, Veozah |
| Lilly USA, LLC | $118.46 | 2019-2021 | |
| Exact Sciences Corporation | $117.64 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $114.16 | 2021-2025 | Farxiga, Airsupra |
| Amgen INC. | $111.33 | 2019-2025 | Krystexxa, Repatha, Otezla |
| Pfizer INC. | $104.99 | 2019-2025 | |
| Dexcom, INC. | $103.40 | 2021-2024 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $90.32 | 2022-2025 | Caplyta |
| Amarin Pharma, INC. | $81.36 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $80.12 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $74.65 | 2019-2023 | |
| Glaxosmithkline, LLC. | $74.61 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lester Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.